David H. Fater, CEO of Vicor Technologies, Inc. (OTCBB: VCRT), announced that its PD2i® nonlinear algorithm has been selected by Dr. Sanjay Sharma to be used in a month-long cardiac screening initiative to be held in South East London in April 2010. Vicor Technologies is a biotechnology company focused on the commercialization of innovative, non-invasive medical devices and diagnostics using its patented, proprietary PD2i® nonlinear algorithm and software to stratify patients at risk of sudden cardiac death or autonomic dysfunction, and trauma victims in need of lifesaving intervention.

Dr. Sharma, consultant cardiologist of Cardiac Risk in the Young (CRY), is spearheading the screening initiative which will offer free cardiac screening to 14 year olds (DOB 1995) living in South East London; 14 is the earliest post-puberty age for which proactive screening is considered viable. Ten percent of the estimated seven million individuals fitting this description are expected to participate. Vicor's PD2i® nonlinear algorithm will be used along with ECG and echocardiogram to identify participants at risk of sudden cardiac death.

"The ultimate goal of this initiative is to develop a prototype for a national screening program for young sudden cardiac death, which is an extremely worthy goal, given that some 600 young people are struck down by sudden cardiac death annually in the U.K. We're honored to have our PD2i® nonlinear algorithm selected for use in this important initiative," stated Dr. Daniel Weiss, cardiologist and Vicor's Chief Medical Officer.

"Given the consistently accurate results achieved with the PD2i® nonlinear algorithm in risk stratifying adults at risk of sudden cardiac death, we're confident that the PD2i® nonlinear algorithm will prove beneficial in identifying 14 year olds participating in the initiative, who will then be able to obtain effective treatment," stated Mr. Fater.

Dr. Sharma was recently-appointed Professor of the newly-created Inherited Cardiovascular Disease and Sports Cardiology Centre at St. George's Healthcare NHS Trust. He will begin his tenure in February 2010. The Inherited Cardiovascular Disease and Sports Cardiology Centre is the world's first specialist, multi-disciplinary facility dedicated to providing services to populations affected by or at risk for (including families and athletes) young (14-35) sudden cardiac death. St. George's is one of England's largest teaching hospitals and the first hospital in the United Kingdom to develop a specialist clinic for young sudden cardiac death after receiving CRY's donation of echocardiogram equipment. CRY was founded in 1996 to raise awareness of conditions that can lead to sudden cardiac death and sudden cardiac death syndrome in those between the ages of 14 and 35.

Source
Vicor Technologies, Inc.